Validation of Whole Blood Rapid Diagnosis Test for Hepatitis B
Author(s) -
José D. Debes,
Gertine van Oord,
André Boonstra
Publication year - 2020
Publication title -
annals of global health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.602
H-Index - 66
ISSN - 2214-9996
DOI - 10.5334/aogh.2866
Subject(s) - medicine , hbsag , point of care testing , hepatitis b virus , whole blood , point of care , rapid diagnostic test , blood test , hepatitis b , test (biology) , diagnostic test , virology , immunology , emergency medicine , virus , pathology , biology , paleontology
We recently published a report validating point-of-care rapid diagnostic tests (RDT) for the diagnosis of Hepatitis B virus (HBV) infection in serum. In the current report, we validated a whole-blood RDT for HBsAg in the form of a test-strip. The test was validated in 55 HBV positive individuals across all genotypes other than F, and in 20 HBV negative individuals in the Netherlands. The RDT showed 100% sensitivity and specificity. The low cost and use in whole blood allows this RDT to be useful in resource-limited locations, further validation in such settings will be of importance.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom